HB
VRTX icon

Horizon Bancorp’s Vertex Pharmaceuticals VRTX Stock Holding History

Horizon Bancorp’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-19
Closed -$7K – 250
2023
Q2 		$7K Sell
19
-24
-56% -$8.09K ﹤0.01% 200
2023
Q1 		$14K Sell
43
-23
-35% -$6.9K 0.01% 129
2022
Q4 		$19K Buy
+66
New +$20.1K 0.01% 150
2020
Q3 		$169K Sell
622
-30
-5% -$8.28K 0.24% 120
2020
Q2 		$189K Sell
652
-245
-27% -$66.4K 0.2% 101
2020
Q1 		$213K Sell
897
-265
-23% -$60.8K 0.33% 85
2019
Q4 		$254K Buy
+1,162
New +$235K 0.24% 117

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Horizon Bancorp's VRTX Position: Q3 2023 in Review

Horizon Bancorp sold out of Vertex Pharmaceuticals (VRTX) in Q3 2023, closing a stake of 19 shares — an estimated $7K sold.

Horizon Bancorp first reported a position in VRTX in Q4 2019 and held it in 7 quarters. The position peaked at $254K in Q4 2019. 1,277 funds tracked by Wall St. Rank hold VRTX as of Q3 2023.

  • Horizon Bancorp reported no remaining Vertex Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Horizon Bancorp sold 19 Vertex Pharmaceuticals shares in Q3 2023, an estimated $7K.
  • Horizon Bancorp first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Horizon Bancorp's Vertex Pharmaceuticals position peaked at $254K in Q4 2019.
  • 1,277 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2023.

Based on Horizon Bancorp's 13F filing for Q3 2023, filed 24 Oct 2023.